Smith Salley Wealth Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.39M Buy
9,120
+194
+2% +$51.2K 0.1% 112
2026
Q2
$1.97M Buy
8,926
+86
+1% +$23.8K 0.09% 124
2026
Q1
$2.61M Buy
8,840
+276
+3% +$82K 0.13% 107
2025
Q4
$2.34M Buy
8,564
+216
+3% +$58.7K 0.12% 115
2025
Q3
$2.26M Buy
8,348
+117
+1% +$31.8K 0.12% 116
2025
Q2
$2.27M Buy
8,231
+211
+3% +$57.4K 0.13% 108
2025
Q1
$2.13M Sell
8,020
-6
-0.1% -$1.48K 0.14% 101
2024
Q4
$1.86M Buy
8,026
+1
+0% +$230 0.12% 108
2024
Q3
$1.77M Buy
8,025
+240
+3% +$49.7K 0.12% 111
2024
Q2
$1.53M Buy
7,785
+19
+0.2% +$3.93K 0.11% 111
2024
Q1
$1.67M Sell
7,766
-3,289
-30% -$691K 0.13% 104
2023
Q4
$2.33M Sell
11,055
-312
-3% -$66.6K 0.15% 101
2023
Q3
$2.28M Sell
11,367
-251
-2% -$49.9K 0.17% 96
2023
Q2
$2.15M Buy
11,618
+287
+3% +$53K 0.16% 97
2023
Q1
$2.17M Buy
11,331
+259
+2% +$46.8K 0.17% 95
2022
Q4
$1.86M Hold
11,072
– – 0.16% 104
2022
Q3
$1.96M Buy
11,072
+86
+0.8% +$17K 0.18% 96
2022
Q2
$2.25M Buy
10,986
+751
+7% +$159K 0.19% 94
2022
Q1
$2.43M Buy
10,235
+142
+1% +$33.3K 0.18% 96
2021
Q4
$2.31M Sell
10,093
-42
-0.4% -$9.24K 0.16% 105
2021
Q3
$1.96M Buy
10,135
+427
+4% +$86.5K 0.15% 105
2021
Q2
$2.06M Buy
9,708
+26
+0.3% +$5.49K 0.17% 99
2021
Q1
$1.98M Buy
9,682
+281
+3% +$55.3K 0.18% 91
2020
Q4
$1.71M Sell
9,401
-190
-2% -$32.3K 0.17% 92
2020
Q3
$1.6M Buy
9,591
+77
+0.8% +$13K 0.19% 89
2020
Q2
$1.55M Buy
+9,514
New +$1.71M 0.21% 84

Other funds holding CME

Smith Salley Wealth Management's CME Position: Q3 2026 in Review

Smith Salley Wealth Management increased its CME Group (CME) stake by 2.2% in Q3 2026, buying an estimated $51.2K and bringing the position to 9,120 shares worth $2.39M. The position accounts for 0.1% of the portfolio, ranked #112.

Smith Salley Wealth Management first reported a position in CME in Q2 2020 and has held it in 26 quarters since. The position peaked at $2.61M in Q1 2026. 1,739 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Smith Salley Wealth Management held 9,120 shares of CME Group worth $2.39M as of Q3 2026.
  • Smith Salley Wealth Management bought 194 CME Group shares in Q3 2026, an estimated $51.2K.
  • CME Group made up 0.1% of Smith Salley Wealth Management's portfolio in Q3 2026, its #112 holding.
  • Smith Salley Wealth Management first reported a position in CME Group in Q2 2020 and has held it in 26 quarters since.
  • Smith Salley Wealth Management's CME Group position peaked at $2.61M in Q1 2026.
  • 1,739 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Smith Salley Wealth Management's 13F filing for Q3 2026, filed 3 Nov 2026.